The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations...
The Wall Street Journal: "Mental-health experts wrestling with how to fit temper tantrums, hoarding and even Internet addiction into the current understanding of mental illness are proposing changes to the field's primary reference for diagnoses for the first time in 16 years. The draft revisions of the Diagnostic and Statistical Manual of Mental Disorders—the bible for mental health clinicians and researchers—unveiled Wednesday could have effects that ripple through mental health care."
There is growing evidence that a procedure for identifying chromosomal abnormalities in embryos prior to in vitro fertilization is ineffective at helping older women become pregnant, the Wall Street Journal reports. The procedure -- known as pre-implantation genetic screening, or PGS -- is performed in dozen of U.S.
As health reform heats up, many lawmakers agree that the government should take a larger role in preventing disease. However, the Wall Street Journal reports that "many previous government prevention efforts aimed at costly chronic diseases have had little success in reducing illness or costs."
The Wall Street Journal on Wednesday examined antiabortion-rights groups' increasing use of Internet videos and other online media to gain new supporters and circulate their message. The Journal reports that the producers behind CatholicVote.
The Wall Street Journal on Wednesday examined antiabortion-rights groups' increasing use of Internet videos and other online media to gain new supporters and circulate their message. The Journal reports that the producers behind CatholicVote.
A growing number of hospitals have stepped up efforts to prevent pulmonary embolisms and deep-vein thrombosis after Medicare recently said it would not provide payments for treatment of the conditions in patients undergoing hip or knee surgery, the Wall Street Journal reports.
A House Energy and Commerce subcommittee on Tuesday is scheduled to conduct a hearing on the issue of ending agreements under which brand-name pharmaceutical companies pay generic drugmakers to delay the launch of less costly versions of top-selling medications, the Wall Street Journal reports.